Is WVE or XERS more undervalued in 2026?

CirclFi compares Wave Life Sciences Ltd. (WVE) and Xeris Biopharma Holdings, Inc. (XERS) using 13 institutional-grade valuation models. WVE has a Quality of Company score of 6.7/10 while XERS scores 8.6/10.

Which is a better buy — WVE or XERS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do WVE and XERS valuations compare?

WVE at $6.58 and XERS at $6.16 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

WVE vs XERS Valuation Comparison 2026 — Intrinsic Value Analysis

WVE

Pharmaceutical Preparations

Wave Life Sciences Ltd.

Quality

6.7

out of 10

Value Trap

LOW

Price

$6.58

Last close

Models

9/13

Active

XERS

Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

Quality

8.6

out of 10

Value Trap

LOW

Price

$6.16

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	WVE Fair Value	WVE Upside	XERS Fair Value	XERS Upside
Bayesian DCF	Intrinsic	$3.41	-48.2%	$1.45	-76.5%
Earnings Power Value	Intrinsic	—	—	$0.13	-97.8%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$3.72	-43.5%	—	—
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for WVE vs XERS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

WVE vs XERS — Which Stock Is More Undervalued?

XERS scores higher with a 8.6/10 quality rating vs WVE's 6.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Wave Life Sciences Ltd. (WVE) and Xeris Biopharma Holdings, Inc. (XERS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

WVE currently trades at $6.58 with a QOC of 6.7/10, while XERS trades at $6.16 with a QOC of 8.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).